Junhui Ma

497 total citations · 1 hit paper
8 papers, 392 citations indexed

About

Junhui Ma is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Junhui Ma has authored 8 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Hematology. Recurrent topics in Junhui Ma's work include Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (5 papers) and Ubiquitin and proteasome pathways (3 papers). Junhui Ma is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (5 papers) and Ubiquitin and proteasome pathways (3 papers). Junhui Ma collaborates with scholars based in China and United States. Junhui Ma's co-authors include Chunquan Sheng, Guoqiang Dong, Shipeng He, Fei Gao, Shanchao Wu, Yuxin Fang, Ying Liu, Wei Wang, Rui Liu and Ying Wu and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Acta Biomaterialia.

In The Last Decade

Junhui Ma

8 papers receiving 390 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer

2021 221 citations Shipeng He, Fei Gao et al. Angewandte Chemie International Edition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junhui Ma China	7	364	176	87	20	17	8	392
Cyrille S. Kounde United Kingdom	7	375 1.0×	213 1.2×	111 1.3×	13 0.7×	34 2.0×	7	448
Koramit Suppipat Thailand	8	169 0.5×	76 0.4×	33 0.4×	18 0.9×	22 1.3×	20	250
Elisa Hahn Austria	5	274 0.8×	123 0.7×	27 0.3×	6 0.3×	25 1.5×	6	303
Conner Craigon United Kingdom	8	439 1.2×	218 1.2×	90 1.0×	4 0.2×	33 1.9×	9	463
Gemma Azaceta Spain	10	75 0.2×	127 0.7×	33 0.4×	8 0.4×	33 1.9×	19	275
Alexandra M. Terry Australia	9	140 0.4×	85 0.5×	41 0.5×	8 0.4×	15 0.9×	14	308
Kristie Darrah United States	8	255 0.7×	78 0.4×	50 0.6×	11 0.6×	28 1.6×	12	289
Ziyang Ye United States	5	363 1.0×	97 0.6×	20 0.2×	14 0.7×	14 0.8×	6	392
Qiangsheng Zhang China	12	295 0.8×	49 0.3×	19 0.2×	36 1.8×	57 3.4×	32	374
Rossella Troia Italy	10	251 0.7×	171 1.0×	258 3.0×	8 0.4×	17 1.0×	15	330

Countries citing papers authored by Junhui Ma

Since Specialization

Citations

This map shows the geographic impact of Junhui Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhui Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhui Ma more than expected).

Fields of papers citing papers by Junhui Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhui Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhui Ma. The network helps show where Junhui Ma may publish in the future.

Co-authorship network of co-authors of Junhui Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Junhui Ma. A scholar is included among the top collaborators of Junhui Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhui Ma. Junhui Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Ma, Junhui, et al.. (2025). Proteolysis-targeting chimera-doxorubicin conjugate nanoassemblies for dual treatment of EGFR-TKI sensitive and resistant non-small cell lung cancer. Acta Biomaterialia. 195. 421–435. 6 indexed citations

2.

Fang, Lei, et al.. (2025). Silica-based EGFR-degrading nano-PROTACs for efficient therapy of non-small cell lung cancer. European Journal of Pharmaceutics and Biopharmaceutics. 210. 114699–114699. 7 indexed citations

3.

Li, Yuying, Xuelian He, Ting Fan, et al.. (2024). Discovery of potent hypoxia-inducible factor-1α (HIF-1α) degraders by proteolysis targeting chimera (PROTAC). Bioorganic Chemistry. 153. 107943–107943. 5 indexed citations

4.

Ma, Junhui, Lei Fang, Meijing Li, et al.. (2024). Folate‐PEG‐PROTAC Micelles for Enhancing Tumor‐Specific Targeting Proteolysis In Vivo. Advanced Healthcare Materials. 13(20). e2400109–e2400109. 15 indexed citations

5.

Dong, Guoqiang, Ying Wu, Junfei Cheng, et al.. (2022). Ispinesib as an Effective Warhead for the Design of Autophagosome-Tethering Chimeras: Discovery of Potent Degraders of Nicotinamide Phosphoribosyltransferase (NAMPT). Journal of Medicinal Chemistry. 65(11). 7619–7628. 54 indexed citations

6.

He, Shipeng, et al.. (2021). Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer. Angewandte Chemie. 133(43). 23487–23493. 18 indexed citations

7.

He, Shipeng, et al.. (2021). Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer. Angewandte Chemie International Edition. 60(43). 23299–23305. 221 indexed citations breakdown →

8.

He, Shipeng, Junhui Ma, Yuxin Fang, et al.. (2020). Homo-PROTAC mediated suicide of MDM2 to treat non-small cell lung cancer. Acta Pharmaceutica Sinica B. 11(6). 1617–1628. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact